Health
Hard choices emerge as link between AstraZeneca vaccine and rare clotting disorder becomes clearer – Science Magazine
Some scientists suggest halving the dose might reduce risks and help protect more people from COVID-19
By Kai Kupferschmidt, Gretchen VogelApr. 11, 2021 , 7:15 AM
Sciences COVID-19 reporting is supported by the Heising-Simons Foundation.
What was a worrisome suspicion four weeks ago is now widely accepted: The AstraZeneca COVID-19 vaccine can, in very rare cases, cause a disorder characterized by dangerous blood clots and low platelet counts. In Europe, at least 222 suspected cases have been reported among 34 million who have received their first dose of the vaccine. More than 30 have died.
Causality…
-
General16 hours agoCoroner to examine treatment of woman who died three days after surgery performed by former Queensland premier’s partner
-
General19 hours agoAlbanese beats drum on economy as trade clouds gather
-
Noosa News18 hours agoSurgeon partner of former premier to testify over his patient’s death
-
Business16 hours agoWhy Antipa, Cettire, Magnetic Resources, and Steadfast shares are pushing higher